enVVeno Medical (NVNO) Retained Earnings (2017 - 2026)

enVVeno Medical's Retained Earnings history runs 10 years deep, the most recent figure standing at -$175.2 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 12.04% year-over-year to -$175.2 million; the TTM figure through Mar 2026 stood at -$175.2 million (down 12.04% YoY), while the FY2025 annual figure was -$171.3 million, down 12.82% from the prior year.
• Retained Earnings was -$175.2 million for Q1 2026 at enVVeno Medical, down from -$171.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$87.2 million in Q1 2022 to a low of -$175.2 million in Q1 2026.
• Historically, Retained Earnings has averaged -$134.2 million across 5 years, with a median of -$135.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings sank 37.71% in 2022, then decreased 12.04% in 2026.
• A 5-year view of Retained Earnings shows it stood at -$106.5 million in 2022, then slipped by 22.08% to -$130.0 million in 2023, then retreated by 16.78% to -$151.9 million in 2024, then fell by 12.82% to -$171.3 million in 2025, then slipped by 2.25% to -$175.2 million in 2026.
• The last three Retained Earnings figures came in at -$175.2 million (Q1 2026), -$171.3 million (Q4 2025), and -$167.6 million (Q3 2025), per Business Quant data.